−4.23 KUSD
About Stem Cell Authority, Ltd.
Sector
Industry
CEO
Chong Yi Yang
Website
Headquarters
Jingan
Founded
2001
FIGI
BBG000J0JJS6
Stem Cell Authority, Ltd. is a clinical-stage biopharmaceutical company committed to the research and development of immune system disease treatments using small molecules and stem cell technology. The company was founded on March 5, 2001 and is headquartered in Shanghai,China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SCAL is 0.0289 USD — it hasn't changed in the past 24 hours. Watch Stem Cell Authority, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Stem Cell Authority, Ltd. stocks are traded under the ticker SCAL.
SCAL stock has risen by 3.21% compared to the previous week, the month change is a 1.35 K% rise, over the last year Stem Cell Authority, Ltd. has showed a 9.53 K% increase.
SCAL reached its all-time high on Apr 26, 2005 with the price of 1.0400 USD, and its all-time low was 0.000001 USD and was reached on Dec 12, 2014. View more price dynamics on SCAL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SCAL stock is 0% volatile and has beta coefficient of −34.31. Track Stem Cell Authority, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Stem Cell Authority, Ltd. there?
Yes, you can track Stem Cell Authority, Ltd. financials in yearly and quarterly reports right on TradingView.
No, SCAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stem Cell Authority, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stem Cell Authority, Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stem Cell Authority, Ltd. stock shows the buy signal. See more of Stem Cell Authority, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.